RecruitingPhase 2NCT07327840
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Studying Disorder of lipid absorption and transport
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kylonova (Xiamen) Biopharma co., LTD.
- Intervention
- Kylo-11 or matched placebo(drug)
- Enrollment
- 204 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2025 – 2028
Study locations (30)
- Peking University First Hospital, Beijing, Beijing Municipality, China
- The First Affiliated Hospital of Baotou Medical College, Baotou, China
- Beijing Anzhen Hospital, Beijing, China
- Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China
- China-Japan Union Hospital of Jilin University, Changchun, China
- The First People's Hospital of Changde, Changde, China
- The Third Xiangya Hospital of Central South University, Changsha, China
- Sichuan Academy of Medical Sciences · Sichuan Provincial People's Hospital, Chengdu, China
- Chongqing University Three Gorges Hospital, Chongqing, China
- The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China
- The First Affiliated Hospital of Dali University, Dali, China
- Daqingshi People's Hospital, Daqing, China
- Guangzhou First People's Hospital, Guangzhou, China
- Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China
- The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07327840 on ClinicalTrials.govOther trials for Disorder of lipid absorption and transport
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT07235046A Study of DII235 in Adults With Elevated Lipoprotein(a)Novartis Pharmaceuticals
- ACTIVE NOT RECRUITINGPHASE2NCT07185776A Study of HRS-5632 in Adult Participants With Elevated Lipoprotein(a) at High Risk for Cardiovascular EventsFujian Shengdi Pharmaceutical Co., Ltd.
- RECRUITINGNCT07324902The Effect of Lipoprotein (a) on Arterial Stiffness, Endothelial Function and Myocardial DeformationUniversity of Athens
- ACTIVE NOT RECRUITINGNCT04156997Extreme Lipids RepositoryUniversity of Texas Southwestern Medical Center
See all trials for Disorder of lipid absorption and transport →